Pfizer’s Covid-19 Drug Arrives in Hong Kong, City’s Leader Says

What’s new: Hong Kong has started treating Covid patients with Merck’s U.S.-made Covid-19 oral drug Molnupiravir while Pfizer’s Paxlovid was also set to arrive Monday, Chief Executive Carrie Lam told a press conference.

The full shipment of Molnupiravir the Hong Kong government purchased last week has arrived in the city, and the first batch of Paxlovid will also arrive on Monday, Lam said the same day. She added the delivery of the following two batches of Paxlovid has been scheduled in the next few months.